Canadian Stocks Slip as CIBC Misses Estimates; Royal Bank, TD Bank Advance Aug 27, 2009
Cardiome Pharma Corp. rose 5 percent to C$4. 82, the biggest gain in three weeks. (Bloomberg -- Canada)
Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares Aug 26, 2009
Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27 ... Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27 ... VANCOUVER, Aug. 25 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) ("Cardiome" or the "Company") announced today that its Board of Directors has authorized management to proceed with a tender offer to purchase for cancellation up to 6,470,588 of its common shares for an aggregate purchase price of up to US$27. (PR Newswire)
Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement Aug 11, 2009
VANCOUVER and DEERFIELD, IL, Aug. 10 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM) and its co-development partner Astellas Pharma US, Inc. ("Astellas") announced today that Astellas will undertake a single confirmatory additional Phase 3 clinical trial of KYNAPID(TM) (vernakalant hydrochloride) Injection for rapid conversion of atrial fibrillation to sinus rhythm ... Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and... (PR Newswire)
Cardiome Announces Management Transition Aug 4, 2009
VANCOUVER, Aug. 3 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that Doug Janzen, formerly President and Chief Business Officer, has been appointed to the role of President and Chief Executive Officer by the Board of Directors, effective immediately ... About Cardiome Pharma Corp. ... Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and... (PR Newswire)
Accounting board's lobbyists stress independence Jun 26, 2009
Jackie Clegg Dodd, wife of the Connecticut Democrat, is on the boards of Javelin Pharmaceuticals Inc., Cardiome Pharma Corp., Brookdale Senior Living and Pear Tree Pharmaceuticals. Report: Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Preventing Honest Disclosures. (Fresno Bee -- Business)
Love in short supply for political spouses Jun 4, 2009
Jackie Dodd serves on the corporate boards of video rental company Blockbuster Inc., assisted living facility operator Brookdale Senior Living Inc., CME Group Inc., which is the parent company of the Chicago Board of Trade and the Chicago Mercantile Exchange; and pharmaceutical makers Cardiome Pharma Corp. and Javelin Pharmaceuticals. She hired an ethics counsel to ensure there were no conflicts with her husband's Senate work before agreeing to take the posts. (Yahoo News -- Politics)
Cardiome to Hold Conference Call Apr 9, 2009
VANCOUVER, April 8 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM) today announced that a teleconference call and webcast will be held at 9:00am Eastern (6:00am Pacific) on Thursday, April 9, 2009 to discuss 2008 financial results and the recently announced agreement with Merck & Co., Inc. ... About Cardiome Pharma Corp. ... Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for... (PR Newswire)
FDA: New heart drug may cut hospitalizations Mar 17, 2009
Cardiome Pharma Corp. and partner Astellas Pharma currently have their own atrial fibrillation drug under review at the FDA. And earlier this month Bristol-Myers Squibb Co. licensed the rights to a comparable drug from two Japanese firms. Copyright 2009 The Associated Press. (MSNBC -- Health)
